Summary: Positive Head interviews MAPS Executive Director Rick Doblin, Ph.D., about the creation of MAPS and his efforts over the past 30 years to integrate psychedelics into science, medicine, and culture. The interview highlights the necessity of honest drug education, the importance of psychedelic research, and investigates how the formation of the new MAPS Public Benefit Corporation (MPBC) will create additional opportunities to further psychedelic research after MDMA is an FDA-approved pharmaceutical medication. “We feel that research is important, but the public education is even more important because the public education really builds support for the research, and we are merging from decades and decades of suppression of research in psychedelics and marijuana,” says Doblin.
Listen to the interview here.
Rick Doblin, Ph.D. is the founder of the non-profit research and educational organization MAPS (Multidisciplinary Association of Psychedelic Studies). In this podcast, hear about his 30-year journey beginning at Harvard researching and advocating for the legalization of certain psychedelic substances, all of the exciting momentum that is currently building in this field after decades of resistance, and how MAPS is on track to legalize MDMA for therapeutic use by 2021.
